Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion - PubMed (original) (raw)
. 2006 Jul 20;25(31):4300-9.
doi: 10.1038/sj.onc.1209464. Epub 2006 Mar 6.
Affiliations
- PMID: 16518408
- DOI: 10.1038/sj.onc.1209464
Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion
H-H Yeh et al. Oncogene. 2006.
Abstract
Malignant pleural effusion (MPE) is a poor prognostic sign for patients with non-small-cell lung cancer (NSCLC). The generation of MPE is largely regulated by vascular endothelial growth factor (VEGF), and upregulation of VEGF by Stat3 has been observed in several types of tumor cells. In this study, we demonstrate constitutively activated Stat3 in several human lung cancer cell lines and in tumor cells infiltrated in the pleurae of patients with adenocarcinoma cell lung cancer (ADCLC) and MPE. The observations suggest that activated Stat3 plays a role in the pathogenesis of ADCLC. In PC14PE6/AS2 cells, a Stat3-positive human ADCLC cell line, autocrine IL-6 activated Stat3 via JAKs, not via Src kinase. PC14PE6/AS2 cells express higher VEGF mRNA and protein than do Stat3-negative PC14PE6/AS2/dnStat3 cells. In an animal model, PC14P6/AS2/dnStat3 cells produced no MPE and less lung metastasis than did PC14P6/AS2 cells. PC14PE6/AS2 cells also expressed higher VEGF protein, microvessel density, and vascular permeability in tumors than did PC14P6/AS2/dnStat3 cells. Therefore, we hypothesize that autocrine IL-6 activation of Stat3 in ADCLC may be involved in the formation of malignant pleural effusion by upregulating VEGF. Higher levels of IL-6 and VEGF were also found in the pleural fluids of patients with ADCLC than in patients with congestive heart failure. The autocrine IL-6/Stat3/VEGF signaling pathway may also be activated in patients with ADCLC and MPE. These findings provide novel targets for the management of MPE.
Similar articles
- Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Yano S, et al. Clin Cancer Res. 2000 Mar;6(3):957-65. Clin Cancer Res. 2000. PMID: 10741721 - Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.
Yeh HH, Chang WT, Lu KC, Lai WW, Liu HS, Su WC. Yeh HH, et al. PLoS One. 2013 Sep 27;8(9):e75287. doi: 10.1371/journal.pone.0075287. eCollection 2013. PLoS One. 2013. PMID: 24086497 Free PMC article. - Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z. Zhang W, et al. Clin Cancer Res. 2008 Oct 15;14(20):6432-9. doi: 10.1158/1078-0432.CCR-07-4401. Clin Cancer Res. 2008. PMID: 18927282 - Animal models of malignant pleural effusion.
Stathopoulos GT, Kalomenidis I. Stathopoulos GT, et al. Curr Opin Pulm Med. 2009 Jul;15(4):343-52. doi: 10.1097/MCP.0b013e32832af07c. Curr Opin Pulm Med. 2009. PMID: 19387350 Review. - The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).
Chen Y, Mathy NW, Lu H. Chen Y, et al. Mol Med Rep. 2018 Jun;17(6):8019-8030. doi: 10.3892/mmr.2018.8922. Epub 2018 Apr 23. Mol Med Rep. 2018. PMID: 29693703 Free PMC article. Review.
Cited by
- Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer.
Hung CH, Wu SY, Yao CD, Yeh HH, Lin CC, Chu CY, Huang TY, Shen MR, Lin CH, Su WC. Hung CH, et al. Nat Commun. 2024 Sep 9;15(1):7885. doi: 10.1038/s41467-024-51831-7. Nat Commun. 2024. PMID: 39251588 Free PMC article. - Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells.
Jougasaki M, Takenoshita Y, Umebashi K, Yamamoto M, Sudou K, Nakashima H, Sonoda M, Kinjo T. Jougasaki M, et al. Int J Mol Sci. 2024 Feb 13;25(4):2232. doi: 10.3390/ijms25042232. Int J Mol Sci. 2024. PMID: 38396907 Free PMC article. - Malignant pleural effusion: current understanding and therapeutic approach.
Gonnelli F, Hassan W, Bonifazi M, Pinelli V, Bedawi EO, Porcel JM, Rahman NM, Mei F. Gonnelli F, et al. Respir Res. 2024 Jan 19;25(1):47. doi: 10.1186/s12931-024-02684-7. Respir Res. 2024. PMID: 38243259 Free PMC article. Review. - Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6.
Ren Y, Guo W, Qiao B. Ren Y, et al. Heliyon. 2023 Sep 20;9(10):e20175. doi: 10.1016/j.heliyon.2023.e20175. eCollection 2023 Oct. Heliyon. 2023. PMID: 37767481 Free PMC article. - MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions.
Marqués M, Pont M, Hidalgo I, Sorolla MA, Parisi E, Salud A, Sorolla A, Porcel JM. Marqués M, et al. Int J Mol Sci. 2023 Sep 13;24(18):14022. doi: 10.3390/ijms241814022. Int J Mol Sci. 2023. PMID: 37762343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous